Actively Recruiting
The Possible Range of No.4sb Lymph Node Dissection of Locally Advanced Distal Gastric Cancer
Led by Tianjin Medical University Cancer Institute and Hospital · Updated on 2025-09-19
400
Participants Needed
1
Research Sites
123 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main purpose of this study is to evaluate the reasonable range of No.4sb lymph node dissection of locally advanced distal gastric cancer.
CONDITIONS
Official Title
The Possible Range of No.4sb Lymph Node Dissection of Locally Advanced Distal Gastric Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Between 18 and 75 years of age
- Pathologically confirmed gastric cancer before surgery
- Treated with radical resection (D2, R0) of gastric cancer with 16 or more lymph nodes removed
- Willing and able to follow the study program
- Physical condition and organ function allow toleration of abdominal surgery
- Provided written informed consent
- Undergoing radical laparoscopic distal subtotal gastrectomy
- Life expectancy of more than 6 months
- No other serious concomitant diseases
- Sufficient organ functions
- No history of chemotherapy or radiotherapy
- Clinical stage T2-4aNxM0
- Karnofsky performance status (KPS) greater than 60
- Eastern Cooperative Oncology Group performance status (ECOG) 0-1
You will not qualify if you...
- Pregnant or breastfeeding
- Serious liver disease such as cirrhosis
- Serious kidney disease
- Serious respiratory disease
- Uncontrolled diabetes or hypertension
- Heart disease with clinical symptoms such as congestive heart failure or coronary heart disease
- Difficult to control arrhythmia or hypertension
- Recent myocardial infarction within 6 months
- Cardiac insufficiency
- Organ transplant patients needing immunosuppressive therapy
- Severe recurrent infections not controlled
- Other serious concomitant diseases
- Other primary malignant tumors within 5 years except curable skin basal cell carcinoma and cervical cancer in situ
- Psychiatric disease requiring treatment
- History of organ transplantation
- Participation in other clinical research within 6 months before or during the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tianjin Medical University Cancer Hospital
Tianjin, Tianjin Municipality, China, 300060
Actively Recruiting
Research Team
B
Bin Ke, MD.
CONTACT
P
Peng Ru Zhang, MD.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here